2025 Pan-Mass Challenge Draws Thousands of Cyclists to Fuel Next Era of Cancer Research

Targeting eIF2A to Halt Melanoma: Study Reveals Key Driver of Cancer Cell Migration

New Study Uncovers Hidden Disease in 42% of Ovarian Cancer Patients in Remission

Dr. Iris Kuss: ARANOTE Trial Results Signal a New Era in Prostate Cancer Treatment

New Radioimmunotherapy Strategy Eradicates Cancer Stem Cells in Ovarian Cancer

First Non-Invasive Endometrial Cancer Detection Test, EdenDx, Launched by Gnosis

Artificial Sweetener Sucralose May Undermine Cancer Immunotherapy, Study Finds

Global Data Warns of Secondary Cancers Linked to CAR-T Therapy, Urging Monitoring

Rewiring Tumor Microenvironment Improved Pancreatic Cancer Treatment

EMA Grants Orphan Drug Designation to Nuvisertib for Rare Blood Cancer Myelofibrosis

Supercharging Chemotherapy with a Mitochondrial Strategy for Lung Cancer Treatment

Promising Results: Jaypirca Outperforms Imbruvica in Landmark Phase 3 CLL/SLL Trial

Advancing ADCs and Bispecifics Across Oncology and Immunology

A Mitochondrial Makeover: Rewiring T Cells to Supercharge Cancer Immunotherapy

From Code to Cure: AI-Designed Proteins Arm T Cells to Precisely Target Cancer

Imfinzi Receives FDA Priority Review as First Immunotherapy for Gastric and GEJ Cancers

Obesity-Related Cancer Deaths Triple in the U.S., Raising Alarming Concern

START and Advarra Unite to Streamline Early-Phase Oncology Trials with Speed

Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors

Promising Targeted Immunotherapy Improves Survival in HPV16+ Cancers

Shane Jacobson Appointed CEO of the American Cancer Society

Leadership Change at V Foundation, Clark Kinlin Appointed Interim CEO

How to Improve Access to CAR T-cell Therapy: The Role of Policy and Innovation

Shining a Light on Lung Cancer: The Promise of Abenacianine

Overcoming Challenges and Expanding Access to CAR T-Cell Therapy

How SkinJect’s Microneedle-Patch Could Improve Skin Cancer Treatment Outcomes

A Patient Advocacy Perspective on Expanding Access to CAR T-cell Therapy

START Hope Hub Connect Patients and Physicians with Faster, Smarter Trial Access

AI-Driven bioX Genetics Platform Slashes Genetic Variant Detection Time

Darzalex Faspro Achieves Outstanding Results in Multiple Myeloma with 95% 4-Year PFS